相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Alpha 7 nicotinic acetylcholine receptor agonist GTS-21 mitigates isoflurane-induced cognitive impairment in aged rats
Fei-Juan Kong et al.
JOURNAL OF SURGICAL RESEARCH (2015)
Safety and clinical effects of EVP-6124 in subjects with Alzheimer's disease currently or previously receiving an acetylcholinesterase inhibitor medication
William James Deardorff et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
Normalizing Effects of EVP-6124, an Alpha-7 Nicotinic Partial Agonist, on Event-Related Potentials and Cognition: A Proof of Concept, Randomized Trial in Patients with Schizophrenia
Sheldon H. Preskorn et al.
JOURNAL OF PSYCHIATRIC PRACTICE (2014)
A Randomized, Placebo-Controlled Study Investigating the Nicotinic α7 Agonist, RG3487, for Cognitive Deficits in Schizophrenia
Daniel Umbricht et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Effects of the nicotinic α7 receptor partial agonist GTS-21 on NMDA-glutamatergic receptor related deficits in sensorimotor gating and recognition memory in rats
Patrick M. Callahan et al.
PSYCHOPHARMACOLOGY (2014)
Efficacy and safety of the alpha7 agonist ABT-126 in mild-to-moderate Alzheimer's dementia
Laura Gault et al.
Alzheimers & Dementia (2013)
A Randomized Exploratory Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) for Cognitive Enhancement in Schizophrenia
Jeffrey A. Lieberman et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Nicotinic acetylcholine receptors: From basic science to therapeutics
Raymond Hurst et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Effects of α7 nicotinic acetylcholine receptor agonists on antipsychotic efficacy in a preclinical mouse model of psychosis
Kathy L. Kohlhaas et al.
PSYCHOPHARMACOLOGY (2012)
Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease
Tanya L. Wallace et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Immediate and Sustained Improvements in Working Memory After Selective Stimulation of alpha 7 Nicotinic Acetylcholine Receptors
Stacy A. Castner et al.
BIOLOGICAL PSYCHIATRY (2011)
In Vivo Pharmacological Characterization of a Novel Selective α7 Neuronal Nicotinic Acetylcholine Receptor Agonist ABT-107: Preclinical Considerations in Alzheimer's Disease
R. Scott Bitner et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Selective α7 nicotinic receptor activation by AZD0328 enhances cortical dopamine release and improves learning and attentional processes
Simon Sydserff et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Pro-Cognitive and Antipsychotic Efficacy of the α7 Nicotinic Partial Agonist SSR180711 in Pharmacological and Neurodevelopmental Latent Inhibition Models of Schizophrenia
Segev Barak et al.
NEUROPSYCHOPHARMACOLOGY (2009)
SSR180711, a novel selective alpha 7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia
Philippe Pichat et al.
NEUROPSYCHOPHARMACOLOGY (2007)
PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer's disease
Ahmadul Kadir et al.
PSYCHOPHARMACOLOGY (2006)
Alzheimer disease: Current concepts and emerging diagnostic and therapeutic strategies
CM Clark et al.
ANNALS OF INTERNAL MEDICINE (2003)
Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease
ZZ Guan et al.
JOURNAL OF NEUROCHEMISTRY (2000)
分享论文
